Many people fear that now the proceedings could be at least as complicated and harassing as before.
US: Official Statement Responding to Gilead Sciences’ Announcement on a Generic Version of Truvada
Even their announcement today leaves Gilead with exclusive rights to Truvada as PrEP for another 15 months and Teva as the only generic manufacturer on the U.S. market. This will do little to reduce the price in a way that will increase access and PrEP4All remains suspicious of the terms and lack of transparency surrounding the Teva settlement.